Tramadol
ADVERTISEMENT
- Molecular formula
- C16H25NO2
- CAS Number
- 27203-92-5
- IUPAC Name
- 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
- Molecular Weight
- 263.38g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2235g/cm3
- Synonyms
- Ultram
Identification
Interesting facts
Interesting Facts about 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
This compound, often referred to in the context of pharmacological research, exhibits intriguing properties that make it a subject of interest among chemists and pharmacologists alike. Below are some key points that highlight its significance:
- Pharmacological Potential: This compound is noted for its potential therapeutic effects, particularly in the realm of neurological research. It may possess properties that could impact serotonin and norepinephrine levels, which are crucial for mood regulation.
- Chemical Structure: The structural composition of this compound includes a cyclohexanol moiety that contributes to its unique biological activity and interactions within the body. The presence of a dimethylamino group enhances its lipophilicity, often affecting how well it can cross biological membranes.
- Importance of Substituents: The methoxy group present in the phenyl ring is significant. Methoxy substitutions are known to modulate the activity of compounds in medicinal chemistry, potentially altering receptor affinity and selectivity.
- Research Applications: Compounds like this one are often investigated for their roles in treating various disorders. Understanding how it interacts with biological systems can lead to new therapies for conditions related to mood disorders or pain management.
- Analytical Techniques: Scientists frequently employ advanced techniques such as mass spectrometry and NMR spectroscopy to analyze and understand the properties and behaviors of this compound in different environments.
As research progresses, compounds like 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol may continue to unveil new insights into therapeutic strategies, thereby proving the adage that "the best is yet to come" in pharmaceutical science.